Related Articles
Clinical evaluation of 4 types of microRNA in serum as biomarkers of esophageal squamous cell carcinoma
Effects of miR‑106b‑3p on cell proliferation and epithelial‑mesenchymal transition, and targeting of ZNRF3 in esophageal squamous cell carcinoma
Downregulation of miR‑106b‑3p increases sensitivity to cisplatin in esophageal cancer cells by targeting TGM3
Serum expression levels of microRNA-382‑3p, -598-3p, -1246 and -184 in breast cancer patients
Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma